Hypertension Diagnostics, Inc. (HDII)

Market Cap	285.00
Revenue (ttm)	3.79M
Net Income (ttm)	-125.39K
Shares Out	284.78M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,428
Average Volume	98,580
Open	0.0000
Previous Close	n/a
Day's Range	0.0000 - 0.0000
52-Week Range	0.0000 - 0.0002
Beta	-38.77
RSI	41.94
Earnings Date	n/a

About Hypertension Diagnostics

Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marker of cardiovascular disease. The company offers CVProfilor DO-2020, which provides a patient’s arterial elasticity indices used in the assessment for u...

• Industry: Shell Companies
• Sector: Financials
• Founded: 1988
• Employees: 3
• Stock Exchange: OTCMKTS
• Ticker Symbol: HDII

Financial Performance

In 2018, Hypertension Diagnostics's revenue was $3.79 million, an increase of 3.11% compared to the previous year's $3.68 million. Losses were -$125,388, -65.98% less than in 2017.